SCHEMBL30953345

SCHEMBL30953345

CC(C)(C)OC(=O)NC(C(=O)Nc1cc(CO[Si](C)(C)C(C)(C)C)ccn1)C(C1CC1)C1CC1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 5/20 0.36
▸ NR3C2 P08235 2/20 0.36
▸ CDK5 Q00535 1/20 0.35
▸ DYRK1A Q13627 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ ACACB O00763 1/20 0.35
▸ ACACA Q13085 1/20 0.35
▸ CCR2 P41597 1/20 0.34
▸ MAPK14 Q16539 2/20 0.34
▸ CYP3A4 P08684 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ MMP1 P03956 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30953236 0.87 CDK5 (0.40) AAK1NR3C2CDK5DYRK1ACDK5R1
SCHEMBL30953276 0.86 AAK1 (0.44) AAK1NR3C2CDK5DYRK1ACDK5R1
SCHEMBL27393604 0.86 AAK1 (0.44) AAK1NR3C2CDK5DYRK1ACDK5R1
SCHEMBL30953293 0.82 AAK1 (0.41) AAK1NR3C2CDK5DYRK1ACDK5R1
SCHEMBL3921965 0.81 IGF1R (0.44) AAK1NR3C2DYRK1AMEN1KMT2A
SCHEMBL30953405 0.80 CYP3A4 (0.40) AAK1NR3C2MEN1KMT2AATM
SCHEMBL30953409 0.80 CYP3A4 (0.40) AAK1NR3C2MEN1KMT2AATM
SCHEMBL30953263 0.79 AAK1 (0.39) AAK1DYRK1AMEN1KMT2AACACB
SCHEMBL30953392 0.79 CCNE1 (0.41) AAK1NR3C2MEN1KMT2AATM
SCHEMBL30953342 0.79 AAK1 (0.38) AAK1NR3C2CDK5DYRK1ACDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback